Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02776969 · ClinicalTrials.gov registry record
A Gene Hunting Study for Familial Papillary Thyroid Cancer
A clinical trial of Thyroid, sponsored by Ohio State University Comprehensive Cancer Center.
- Active
- Registry status
- 1,200
- Enrollment target
- 1
- Study location
NCT02776969 is a study of Thyroid that is active but no longer recruiting, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 1,200 participants, above the 104-participant average among 5 other Thyroid trials with a reported enrollment target (1054% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02776969, a study of Thyroid, is active but no longer recruiting, sponsored by Ohio State University Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 1,200 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this project is to identify genetic risk factors associated with familial papillary thyroid carcinoma (PTC). Papillary thyroid cancer is a type of cancer that shows high heritability. However, the specific genetic factors that cause an increased risk have been elusive.
Conditions Studied
Study Locations (1)
Ohio
- Ohio State University Comprehensive Cancer Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 1998-08-05 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02776969
The ClinicalTrials.gov registry entry for NCT02776969 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 104-participant average among 5 other Thyroid trials with a reported enrollment target (1054% higher). The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Thyroid appearing as the primary indexed condition, and to 0 interventions.
NCT02776969 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT02776969 about?
NCT02776969 is a clinical study titled "A Gene Hunting Study for Familial Papillary Thyroid Cancer". The aim of this project is to identify genetic risk factors associated with familial papillary thyroid carcinoma (PTC). Papillary thyroid cancer is a type of cancer that shows high heritability. However, the specific genetic factors that cause an increased risk have been elusive.
What is the current status of trial NCT02776969?
This trial is currently active not recruiting. The enrollment target is 1,200 participants. The study started on 1998-08-05. Estimated completion is 2026-12.
What conditions does trial NCT02776969 study?
This clinical trial studies the following conditions: Thyroid.
Who is sponsoring clinical trial NCT02776969?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02776969 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thyroid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treatment of ARDS With Instilled T3
RECRUITING · Phase 2
-
Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors
RECRUITING
-
A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
RECRUITING
-
Laser Ablation of Papillary Thyroid Microcarcinoma
ACTIVE NOT RECRUITING · Phase 2
-
Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.